The Role of Gnrh Analogues in 36-Month Disease-Free Survival in Non-Menopausal Patients with Hormone Receptor-Positive Breast Cancer
BACKGROUND AND OBJECTIVE: The effectiveness of ovarian function suppression therapies in patients with non-menopausal breast cancer has not yet been established. This study was performed to evaluate the role of gonadotropin-releasing hormone agonist (GnRH agonist) receptor in reducing local recurren...
Guardado en:
Autores principales: | S Akbarzadeh Pasha, A Gholizadeh Pasha, M Raanaee, A Moghadamnia, A Vallard, D Moslemi |
---|---|
Formato: | article |
Lenguaje: | EN FA |
Publicado: |
Babol University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b9ce32c676f44879abf4106d476d79b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluación del efecto agudo de la administración de GnRH sobre la secreción de leptina en mujeres sanas e hiperandrogénicas.
por: Maliqueo Y,Manuel, et al.
Publicado: (2000) -
TUMORAL AND NON TUMORAL PITUITARY LESIONS AND REPRODUCTIVE SYSTEM
por: I. A. Ilovayskaya
Publicado: (2012) -
p53 Mediates GnRH Secretion via Lin28/let-7 System in GT1-7 Cells
por: Chen T, et al.
Publicado: (2020) -
Oxidative stress and biochemical markers in prenatally androgenized sheep after neonatal treatment with GnRH agonist
por: Nóbrega JE, et al.
Publicado: (2019) -
Fixed Gonadotropin-Releasing Hormone Antagonist Protocol Versus Flexible Progestin-Primed Ovarian Stimulation Protocol in Patients With Asynchronous Follicular Development During Controlled Ovulation Stimulation: A Retrospective Study
por: Mei Dong, et al.
Publicado: (2021)